Financial incentives were found to increase recruitment of teenage girls to a quit smoking intervention and helped to retain them in the study [ 58, 59].
Cockburn and colleagues conducted a randomized controlled trial in which the effectiveness of three approaches to marketing a quit smoking intervention kit to physicians was evaluated [ 27].
The proportion of individuals who quit smoking in the intervention group (41%) was significantly greater than in the control group (8%) (p = 0.04) (Table 3).
Despite designing a smoking cessation intervention that was based on the best available scientific evidence, this randomised trial failed to demonstrate significant improvement in smokers' cessation rates or intention to quit smoking when the intervention was offered opportunistically for patients attending routine consultations in general practice.
For smokers who have no intention to quit, smoking-reduction interventions may be a therapeutic choice [ 15, 16].
Owing to the addictive properties of tobacco, patients with early COPD are very frequently unable to quit smoking, even with intensive interventions.
These results underlined the importance of health care interventions helping to quit smoking prior to conception and that targeted interventions must comprise cessation of household smoking for the prevention of chronicle diseases such as allergies and obesity in their children.
Outcomes are self-reported 24-hour quit attempts, progression along the stages of change and 7-day point prevalence quit smoking rates for the intervention group compared to usual care alone.
In objective one, we will compare the (1) proportion of individuals that make a self-reported 24-hour quit attempt, (2) progression through the stages of change [ 25, 26] and (3) 7-day point prevalence quit smoking rates for the intervention group to usual care alone.
Additionally, we found that baseline smokers in the intervention group who had not quit smoking 6 months after the intervention were three times more likely to report that they decreased the amount of cigarettes they smoke by at least half a pack.
Future studies examining genetic influences on smoking cessation may prove more informative if they are designed to completely characterize variation in the genes of interest, or to more effectively identify subgroups of smokers who are more genetically inclined to quit smoking or for whom certain pharmacologic interventions may be more efficacious.
